Buscar | Redinv

Nitin Jadhav agrega un archivo Health
2026-03-14 07:12:09 -

Antimicrobial Susceptibility Test Market Strategic Forecast USD 3.8 Billion to USD 8.3 Billion by 2035
The global antimicrobial susceptibility test (AST) market is poised for a decade of rapid expansion, with its valuation projected to rise from USD 3.8 billion in 2025 to USD 8.3 billion by 2035. According to a comprehensive market analysis by Fact.MR, the industry is advancing at a compound annual growth rate (CAGR) of 8.1%, fueled by a global mandate to combat...

0 Commentarios 0 Acciones 693 Views

Please log in to like, share and comment!
Yuva Raj agrega un archivo Health
2026-03-10 03:55:29 -

Antimicrobial Susceptibility Testing Market Growth Forecast 2025 To 2032
Market Overview Antimicrobial Susceptibility Testing (AST) refers to diagnostic procedures used to determine the efficacy of specific antimicrobial agents against bacterial, fungal, or other microbial pathogens. These tests are crucial for guiding clinicians in selecting the most appropriate antimicrobial therapy, thereby improving patient outcomes, and minimizing the development of...

0 Commentarios 0 Acciones 720 Views

Please log in to like, share and comment!
Aishu Chavan agrega un archivo Other
2026-04-01 11:20:56 -

Colloidal Silver Market to Witness Robust Growth by 2036
The Colloidal Silver Market is projected to expand from USD 7.30 billion in 2026 to USD 17.93 billion by 2036, registering a CAGR of 9.4% over the forecast period. Growth is being driven by stricter material governance across healthcare programs, consumer channels, and industrial formulations, where stakeholders prioritize particle size control, repeatable quality outcomes, and comprehensive...

0 Commentarios 0 Acciones 191 Views

Please log in to like, share and comment!
Aishu Chavan agrega un archivo Other
2026-04-01 11:24:03 -

Colloidal Silver Market to Witness Robust Growth by 2036
The Colloidal Silver Market is projected to expand from USD 7.30 billion in 2026 to USD 17.93 billion by 2036, registering a CAGR of 9.4% over the forecast period. Growth is being driven by stricter material governance across healthcare programs, consumer channels, and industrial formulations, where stakeholders prioritize particle size control, repeatable quality outcomes, and comprehensive...

0 Commentarios 0 Acciones 208 Views

Please log in to like, share and comment!